TherapeuticsMD Coverage Initiated by Analysts at Cowen and Company (NYSEAMEX:TXMD)
Stock analysts at Cowen and Company initiated coverage on shares of TherapeuticsMD (NASDAQ:NYSEAMEX:TXMD) in a report issued on Wednesday, Analyst Ratings News reports. The firm set an “outperform” rating on the stock.
Separately, analysts at Stifel Nicolaus initiated coverage on shares of TherapeuticsMD in a research note to investors on Friday, November 1st. They set a “buy” rating on the stock.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.